Christel Franchet
Corporate Officer/Principal at Domain Therapeutics SA
Christel Franchet active positions
| Companies | Position | Start | End |
|---|---|---|---|
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Corporate Officer/Principal | - | - |
Career history of Christel Franchet
Former positions of Christel Franchet
| Companies | Position | Start | End |
|---|---|---|---|
| Hoffmann La Roche France | Corporate Officer/Principal | 01/01/2001 | 01/01/2001 |
Euroclide SA
 Euroclide SA Miscellaneous Commercial ServicesCommercial Services Part of Domain Therapeutics SA, Euroclide SA is a French drug research company. The company was founded by Christel Franchet. Euroclide was acquired by Domain Therapeutics SA on December 22, 2003. | Founder | 01/01/2001 | - |
Training of Christel Franchet
| University of Strasbourg | Doctorate Degree |
Statistics
International
| France | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
| Hoffmann La Roche France | |
Euroclide SA
Euroclide SA Miscellaneous Commercial ServicesCommercial Services Part of Domain Therapeutics SA, Euroclide SA is a French drug research company. The company was founded by Christel Franchet. Euroclide was acquired by Domain Therapeutics SA on December 22, 2003. | Commercial Services |
- Stock Market
- Insiders
- Christel Franchet
- Experience
